The business of longevity
How OnCore Longevity intends to turn the science of living longer into the most scalable franchise model of the decade.
The world’s scarcest asset is not listed on any exchange. It is time, and someone has finally worked out how to package it.
The search for a longer, healthier life has stopped being an eccentricity of Silicon Valley billionaires or a pastime for biohackers. It has become, without exaggeration, the retail category with the greatest disruptive potential of this decade.
It is no accident that figures such as Tony Robbins are investing heavily in the sector and popularising the concept of healthspan: the maximisation of years lived in full health and vitality, not merely the quantity of years lived. Where such figures educate the market, smart capital follows closely. It is at this inflection point that OnCore Longevity, a brand operated by its parent company Medical Exercise Inc. (MEI), chooses to position itself, converting the complex science of longevity into a plug-and-play franchise model built for scale.
To understand how the promise lands on the balance sheet, we looked closely at the strategy of Matt Degelman, president of MEI. The portrait that emerges is not that of another gym chain. It is that of an aggressive investment thesis, driven by efficiency, cutting-edge technology and the retention of a high-net-worth clientele.
The business of wellness, in numbers
Consumer patterns
Source: Global Wellness Institute, Global Wellness Economy Monitor 2025.
It is not a gym. It is an investment thesis dressed as a clinic.
The company: reinventing the format
Behind OnCore Longevity sits Medical Exercise Inc., a franchisor led by Matt Degelman, who holds the roles of president, treasurer and secretary. The company’s ambition is not to open another wellness chain. It is to industrialise longevity medicine: to take what today exists only in boutique clinics, expensive and dependent on physicians, and turn it into a format that is replicable, automated and available at franchise scale.
This is where the company positions itself as an innovator. Where elite longevity clinics operate bespoke, with large clinical teams and high cost, OnCore inverts the logic. It places artificial intelligence at the centre of the operation, lets the equipment read each client’s body and strips the structure back to the essential. What was a concierge service becomes a product. What was the exception becomes the system. The underlying bet is blunt: the next frontier of wellness belongs not to whoever has the best doctor, but to whoever has the best software.
The thesis: high technology, low friction
For the investor, the traditional big-box gym model carries chronic flaws: excess floor space, high maintenance costs, bloated payrolls and elevated churn. OnCore attacks each of these inefficiencies head-on.
Degelman rejects the gym label. The OnCore Longevity Centers are conceived as clinical, technological installations. The backbone of the operation is the integration with equipment from Germany’s EGYM: machines that automatically adjust resistance, range and cadence based on each user’s biometric profile, guided by artificial intelligence.
From a business standpoint, this solves two monumental bottlenecks. The first is customer churn. The method calls for only two twenty-minute sessions a week, which dissolves the barrier of a lack of time, the leading reason for cancellation at gyms. The second is payroll cost. Extreme automation drastically reduces the need for a large contingent of personal trainers and floor staff in the day-to-day running of each unit.
The promise is ambitious: to reverse cellular ageing, preserve muscle mass, what the company calls the definitive organ of longevity, and maintain metabolic flexibility. A proposition tailored to a premium audience, willing to pay a higher average ticket for efficient, data-driven results.
The ecosystem: where revenue multiplies
The profitability of a wellness franchise depends on its capacity to generate additional sales. OnCore structures the business to capture value well beyond the membership fee.
The brand integrates AI-driven nutritional prescription, aligned with a dispensary of clinical-grade supplements and a service delivering meals with precise macros to the client’s home. For the franchisee, the result is a set of recurring revenue lines and a substantial increase in each user’s Lifetime Value.
We remove the friction of living a longevity-focused lifestyle.Matt Degelman, president, MEI
The first-mover race
The window for institutional investors and master franchisees is open, but competition is heating up fast. The longevity market is living through a moment of land grab.
One need only observe the competition. In July 2026, the Ultimate Longevity Center, driven by Anthony Geisler, the executive who scaled Club Pilates to more than a thousand studios, in partnership with Lifeforce, the platform that counts Tony Robbins among the names behind it, and with biologist Gary Brecka, announced the sale of 200 franchise territories in just four months, before even opening its first unit.
The rival’s success is not a threat. It is the definitive validation of the model. OnCore enters this already-validated blue ocean with a proposition anchored in hyper-personalisation and automation.
There are concrete reasons to take the bet seriously. The pattern OnCore is pursuing has been walked before, and successfully. Anthony Geisler turned Club Pilates into more than a thousand studios; wellness franchising has produced unicorns over the past decade; and the category grows faster than global GDP, year after year. OnCore is not inventing a market, it is entering territory already validated by those who arrived first, with the advantage of a more automated, more personalised proposition. For anyone who understands timing, this is not a speculative thesis: it is the repetition of a script that has already worked, now applied to the frontier of longevity. The risk remains, and it is real, but the underlying logic has ballast.
The road to the capital markets
The execution of the thesis begins in Canada. OnCore’s first flagship unit is scheduled to open, with sales onboarding, on 1 September 2026, in the city of Regina. More than a wellness centre, the flagship functions as a conversion laboratory and a shop window for the unit economics of the network’s global expansion.
Behind the scenes, the corporate structure points to greater ambitions. Medical Exercise Inc., the franchisor and parent company, is already working through the regulatory processes with the aim of listing its shares on the OTCQB market. For the early-stage investor, the pre-listing, pre-revenue status, subject, naturally, to regulatory approvals, represents the entry point of greatest risk and, in the same movement, of greatest upside before the brand gains institutional traction.
Why the market is watching
In the end, longevity rests on ancestral principles: movement and nutrition. The business of longevity, however, demands packaging, scale and convenience. OnCore Longevity is not merely selling more years of life to the client. It is selling, to the investor, a model built to multiply.
Time remains the only luxury no one manufactures. What is on sale now is the promise of managing it.
OnCore Longevity: oncorelongevity.com
Gabriel Silveirado, for WAYFARER.
